These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 9578718

  • 1. Quantitative defect in staphylococcal enterotoxin A binding and presentation by HLA-DM-deficient T2.Ak cells corrected by transfection of HLA-DM genes.
    Albert LJ, Denzin LK, Ghumman B, Bangia N, Cresswell P, Watts TH.
    Cell Immunol; 1998 Jan 10; 183(1):42-51. PubMed ID: 9578718
    [Abstract] [Full Text] [Related]

  • 2. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
    Albert LJ, Ghumman B, Watts TH.
    J Immunol; 1996 Sep 15; 157(6):2247-55. PubMed ID: 8805621
    [Abstract] [Full Text] [Related]

  • 3. Chemical chaperones enhance superantigen and conventional antigen presentation by HLA-DM-deficient as well as HLA-DM-sufficient antigen-presenting cells and enhance IgG2a production in vivo.
    Ghumman B, Bertram EM, Watts TH.
    J Immunol; 1998 Oct 01; 161(7):3262-70. PubMed ID: 9759841
    [Abstract] [Full Text] [Related]

  • 4. Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes.
    Brooks AG, Campbell PL, Reynolds P, Gautam AM, McCluskey J.
    J Immunol; 1994 Dec 15; 153(12):5382-92. PubMed ID: 7989744
    [Abstract] [Full Text] [Related]

  • 5. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L, Kovats S, Eastman S, Rudensky AY.
    J Immunol; 1996 Mar 15; 156(6):2196 - 2204. PubMed ID: 8690909
    [Abstract] [Full Text] [Related]

  • 6. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J, König A, Koch N.
    Int Immunol; 2007 Jan 15; 19(1):31-9. PubMed ID: 17105964
    [Abstract] [Full Text] [Related]

  • 7. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM, Azar GA, Mourad W, Routy JP, Boulassel MR, Denzin LK, Thibodeau J.
    Hum Immunol; 2013 Oct 15; 74(10):1280-7. PubMed ID: 23756162
    [Abstract] [Full Text] [Related]

  • 8. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
    Karlsson L.
    Curr Opin Immunol; 2005 Feb 15; 17(1):65-70. PubMed ID: 15653313
    [Abstract] [Full Text] [Related]

  • 9. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines.
    Kovats S, Whiteley PE, Concannon P, Rudensky AY, Blum JS.
    Eur J Immunol; 1997 Apr 15; 27(4):1014-21. PubMed ID: 9130658
    [Abstract] [Full Text] [Related]

  • 10. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
    Wen R, Broussard DR, Surman S, Hogg TL, Blackman MA, Woodland DL.
    Eur J Immunol; 1997 Mar 15; 27(3):772-81. PubMed ID: 9079821
    [Abstract] [Full Text] [Related]

  • 11. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB, Arndt SO, Hämmerling GJ, Kropshofer H.
    Semin Immunol; 1999 Dec 15; 11(6):391-403. PubMed ID: 10625593
    [Abstract] [Full Text] [Related]

  • 12. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
    Morris P, Shaman J, Attaya M, Amaya M, Goodman S, Bergman C, Monaco JJ, Mellins E.
    Nature; 1994 Apr 07; 368(6471):551-4. PubMed ID: 8139689
    [Abstract] [Full Text] [Related]

  • 13. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
    Singh N, Van Kaer L.
    J Immunol; 1999 Oct 01; 163(7):3583-91. PubMed ID: 10490950
    [Abstract] [Full Text] [Related]

  • 14. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
    Monji T, McCormack AL, Yates JR, Pious D.
    J Immunol; 1994 Nov 15; 153(10):4468-77. PubMed ID: 7525705
    [Abstract] [Full Text] [Related]

  • 15. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hämmerling GJ.
    EMBO J; 1996 Nov 15; 15(22):6144-54. PubMed ID: 8947036
    [Abstract] [Full Text] [Related]

  • 16. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
    Busch R, Doebele RC, von Scheven E, Fahrni J, Mellins ED.
    J Immunol; 1998 Jan 15; 160(2):734-43. PubMed ID: 9551909
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.
    Chamuleau ME, Souwer Y, Van Ham SM, Zevenbergen A, Westers TM, Berkhof J, Meijer CJ, van de Loosdrecht AA, Ossenkoppele GJ.
    Cancer Res; 2004 Aug 15; 64(16):5546-50. PubMed ID: 15313888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.